Biogen takes Creative Biolabs to court over antibody

19-03-2020

Sarah Morgan

Biogen takes Creative Biolabs to court over antibody

PictureDesignSwiss / Shutterstock.com

Biogen and the University of Zurich have accused New York-based Creative Biolabs of unlawfully selling copies of Biogen’s aducanumab antibody. 


Biogen, University of Zurich, Creative Biolabs, patent infringement, antibodies, aducanumab, Alzheimer’s

LSIPR